The current state of bariatric endoscopy

Thomas R. McCarty, Christopher C. Thompson

Research output: Contribution to journalReview articlepeer-review

17 Scopus citations


A variety of endoscopic bariatric and metabolic treatments (EBMTs) have been developed in recent years to combat the growing prevalence of obesity in the United States (US) and worldwide. This manuscript reviews the current state of bariatric endoscopy, detailing all US Food and Drug Administration (FDA) approved EBMTs including space-occupying intragastric balloons (IGBs), aspiration therapy, and endoscopic tissue apposition devices. Additionally, this review describes non-FDA approved treatments including additional IGBs, endoluminal bypass liners, duodenal mucosal resurfacing, and endoscopically placed anastomosis devices.

Original languageEnglish (US)
Pages (from-to)321-334
Number of pages14
JournalDigestive Endoscopy
Issue number3
StatePublished - Mar 2021


  • bariatric endoscopy
  • endoscopic bariatric and metabolic treatments (EBMTs)
  • obesity
  • weight loss

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Gastroenterology


Dive into the research topics of 'The current state of bariatric endoscopy'. Together they form a unique fingerprint.

Cite this